35.33MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.14
Dividend Share
-
Dividend Yield
-
Earnings Share
-
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
157,220
Gross Profit TTM
48,952
EBITDA
-
Profit Margin
0.00%
Return On Assets TTM
-759.60%
Return On Equity TTM
-3956.02%
Revenue Per Share TTM
0.05
Qtly Revenue Growth YOY
662.70%
Diluted Eps TTM
0
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
0
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
290.59
4.74%271.40
1.07%477.99
0.93%139.01
0.71%656.01
0.61%81.96
0.00%89.50
-2.82%915.00
-1.11%20.00
-0.79%325.90
-0.26%